Chris Skennerton

Business Support Manager at 4Cyte Pathology - North Ryde, New South Wales, AU

Chris Skennerton's Contact Details
HQ
N/A
Location
Company
4Cyte Pathology
Chris Skennerton's Company Details
4Cyte Pathology logo, 4Cyte Pathology contact details

4Cyte Pathology

North Ryde, New South Wales, AU • 476 Employees
Hospital/Clinic

4Cyte Pathology is an independent specialist medical laboratory and pathology provider based in NSW and Victoria, Australia. Our pathology professionals are highly regarded in their respective fields, with many having held peak clinical, scientific and pathology leadership roles in Australia’s leading private and public medical / pathology laboratories. 4Cyte was founded in 2018 by James Bateman with the stated aim of combining world-leading pathology expertise together with the latest analytical technology to deliver improved diagnostic insights to clinicians and their patients. We are Australia’s only multi-state independent specialist private medical laboratory, providing a comprehensive range of specimen collection and testing services including: haematology, chemistry, toxicology, microbiology, cytology, molecular diagnostics, cardiology and infectious serology. If we can assist your medical practice and your patients, or to express interest in joining our expanding 4Cyte team please feel free to contact us 13 4CYTE or support@4cyte.com.au

Pathology Services Diagnostics Testing
Details about 4Cyte Pathology
Frequently Asked Questions about Chris Skennerton
Chris Skennerton currently works for 4Cyte Pathology.
Chris Skennerton's role at 4Cyte Pathology is Business Support Manager.
Chris Skennerton's email address is ***@4cyte.com.au. To view Chris Skennerton's full email address, please signup to ConnectPlex.
Chris Skennerton works in the Hospital/Clinic industry.
Chris Skennerton's colleagues at 4Cyte Pathology are Lynne Chand, Adrian McCormack, Amelia Hong, Connor McCormick, David Kajzer, Harshitha Kumar, Jonathan Thompson and others.
Chris Skennerton's phone number is N/A
See more information about Chris Skennerton